Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Cardiovascular risk and estrogens].

J Franeková1, P Koliba, A Jabor

  • 1Ustav klinické biochemie, Fakultní nemocnice s poliklinikou, Ostrava, Poruba.

Ceska Gynekologie
|January 24, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Diagnostic pitfalls in ovarian androgen-secreting (Leydig cell) tumours: case series.

Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology·2018
Same author

[Endometriosis and quality of life].

Ceska gynekologie·2017
Same author

Sensitivity to perioperative ischemia/reperfusion injury in male and female donor myocardium.

Physiological research·2017
Same author

Human papillomavirus deoxyribonucleic acid testing in screening of high grade cervical intraepithelial neoplasia.

Saudi medical journal·2016
Same author

The importance of age and statin therapy in the interpretation of Lp-PLA(2) in ACS patients, and relation to CRP.

Physiological research·2014
Same author

[Basic principles of diagnosis and treatment of secondary peritonitis - recommendations of experts with the support of SIS].

Rozhledy v chirurgii : mesicnik Ceskoslovenske chirurgicke spolecnosti·2014
Same journal

ESGO/ISUOG guidelines for needle biopsies in gynecologic oncology - the adapted version.

Ceska gynekologie·2026
Same journal

Impact of selected dimensions of pelvic floor structures on the process of delivery - a review of the literature.

Ceska gynekologie·2026
Same journal

Limits of preeclampsia screening and prevention in a population of women after assisted reproductive technologies.

Ceska gynekologie·2026
Same journal

Clinically relevant histopathological features and biomarkers in endometrial cancer.

Ceska gynekologie·2026
Same journal

Vulvodynia and persistent vulvar pain - diagnosis, treatment, and the role of laser vaporization.

Ceska gynekologie·2026
Same journal

Endometrioma of Bartholin's gland.

Ceska gynekologie·2026
See all related articles

Postmenopause alters lipid metabolism, increasing cardiovascular disease risk. While hormone therapy has some benefits, recent data suggest it may be less beneficial or even risky for atherosclerosis.

Area of Science:

  • Endocrinology
  • Cardiovascular Medicine
  • Lipidology

Context:

  • Menopause is associated with significant alterations in lipid metabolism and an elevated risk of cardiovascular diseases.
  • Estrogen deficiency negatively impacts lipid profiles and vascular health.
  • Understanding these changes is crucial for managing postmenopausal women's health.

Purpose:

  • To elucidate the complex relationship between postmenopause, hormone therapy, lipid metabolism, and cardiovascular disease (CVD) risk.
  • To analyze the effects of estrogen on vascular walls and lipid profiles.
  • To evaluate current cardiovascular risk assessment methods and guidelines in postmenopausal women.

Summary:

  • Postmenopause significantly affects lipid metabolism and increases CVD risk due to estrogen deficit.

Related Experiment Videos

  • Estrogen therapy presents a dual effect, offering potential vascular benefits alongside risks like increased triglycerides, atherogenic LDL particles, inflammation, and procoagulation.
  • Current evidence suggests hormonal therapy may offer limited benefits and potential risks concerning atherosclerosis and CVD.

    • Impact:

    • Provides a comprehensive overview of menopausal effects on cardiovascular health.
    • Highlights the nuanced role of hormone therapy in managing lipid metabolism and CVD risk.
    • Informs clinical practice and future research directions for postmenopausal cardiovascular risk reduction.